Sein métastatique RH+
SERENA-2 (D8530C00002)
SERENA-2: A Randomised, Open-Label, Parallel-Group, Multicentre Phase;2 Study Comparing the Efficacy and Safety of Oral AZD9833 versus;Fulvestrant in Women with Advanced ER-Positive HER2-Negative Breast;Cancer
Paris
FRANCOIS-CLEMENT BIDARD